Aptinyx Inc.

Company Listings from SPi: Aptinyx Inc.

You are here: Home >> SPi Company Listings >> Aptinyx Inc.

 

Aptinyx Inc.

Website:
http://

Search for other references to "aptinyx" on SPi News

Latest Aptinyx Inc. News

Robust Analgesic Activity of Aptinyx’s NYX-2925 in Advanced DPN Patients Revealed Through Further Analysis of Data from Phase 2 Study EVANSTON, Ill., April 18, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment o...... 12:27 GMT Thursday 18th April 2019

Aptinyx to Present Detailed Results from Phase 2 Painful DPN Study of NYX-2925 at American Pain Society Scientific Meeting EVANSTON, Ill., March 28, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment...... 11:07 GMT Thursday 28th March 2019

Aptinyx to Present Preclinical Data on NYX-458 at the AD/PD 14th International Conference on Alzheimer’s & Parkinson’s Diseases EVANSTON, Ill., March 22, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment o...... 11:27 GMT Friday 22nd March 2019

Aptinyx Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress EVANSTON, Ill., March 21, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment o...... 11:07 GMT Thursday 21st March 2019

Aptinyx to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 21, 2019 EVANSTON, Ill., March 14, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment o...... 12:00 GMT Thursday 14th March 2019

Aptinyx to Present at Cowen and Company 39th Annual Health Care Conference EVANSTON, Ill., March 06, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment o...... 13:00 GMT Wednesday 6th March 2019

Aptinyx to Present at 8th Annual SVB Leerink Global Healthcare Conference EVANSTON, Ill., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of...... 13:00 GMT Friday 22nd February 2019

Aptinyx Initiates Phase 2 Study to Evaluate Safety and Efficacy of NYX-783 in Patients with Post-Traumatic Stress Disorder EVANSTON, Ill., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of...... 12:27 GMT Tuesday 19th February 2019

Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy EVANSTON, Ill., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of...... 12:27 GMT Wednesday 16th January 2019

Aptinyx to Present at 37th Annual J.P. Morgan Healthcare Conference EVANSTON, Ill., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment o...... 13:07 GMT Wednesday 2nd January 2019

Buy Aptinyx Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us